MacPhee departs Strativa Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Par Pharmaceuticals reported that John MacPhee has resigned his positions as president of Strativa Pharmaceuticals and executive vice-president of Par Pharmaceuticals, Strativa's parent compant, to pursue other interests effective 31 January, 2011. Mr Patrick LePore, chairman, CEO and president of Par, will assume day-to-day oversight of Strativa.